Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database

被引：0
|
作者：
Megan C. Roberts
Dave P. Miller
Steven Shak
Valentina I. Petkov
机构：
[1] National Cancer Institute,
[2] Genomic Health Inc.,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词：
Breast cancer; Disease-specific survival; Lymph node-positive; Oncotype DX; Recurrence Score; SEER;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 310
页数：7
相关论文
共 50 条
  • [41] Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients
    Suner, Ali
    Buyukhatipoglu, Hakan
    Aktas, Gokmen
    Kus, Tulay
    Ulasli, Mustafa
    Oztuzcu, Serdar
    Kalender, Mehmet Emin
    Sevinc, Alper
    Kul, Seval
    Camci, Celaletdin
    ONCOTARGETS AND THERAPY, 2016, 9 : 5603 - 5609
  • [42] Disparities in Hormone Receptor-Positive Breast Cancer
    Ogayo, Esther R.
    Mittendorf, Elizabeth A.
    Kantor, Olga
    CURRENT BREAST CANCER REPORTS, 2024, 16 (01) : 106 - 115
  • [43] Disparities in Hormone Receptor-Positive Breast Cancer
    Esther R. Ogayo
    Elizabeth A. Mittendorf
    Olga Kantor
    Current Breast Cancer Reports, 2024, 16 : 106 - 115
  • [44] Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer
    Aline Baltres
    Zeina Al Masry
    Ryad Zemouri
    Severine Valmary-Degano
    Laurent Arnould
    Noureddine Zerhouni
    Christine Devalland
    Breast Cancer, 2020, 27 : 1007 - 1016
  • [45] Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer
    Baltres, Aline
    Al Masry, Zeina
    Zemouri, Ryad
    Valmary-Degano, Severine
    Arnould, Laurent
    Zerhouni, Noureddine
    Devalland, Christine
    BREAST CANCER, 2020, 27 (05) : 1007 - 1016
  • [46] Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer
    Sestak, Ivana
    Zhang, Yi
    Schroeder, Brock E.
    Schnabel, Catherine A.
    Dowsett, Mitch
    Cuzick, Jack
    Sgroi, Dennis
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5043 - 5048
  • [47] Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer
    Zhu, Jingjing
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Yu, Kaijie
    Wu, Lunpo
    Li, Dan
    Zhou, Shishi
    Tang, Wanfen
    Wang, Qinghua
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Du, Jinlin
    Fu, Jianfei
    CLINICAL BREAST CANCER, 2022, 22 (03) : E296 - E309
  • [48] Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer
    Sakin, Aysegul
    Aldemir, Mehmet Naci
    EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (04) : 270 - 275
  • [49] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [50] The lymph node ratio as prognostic factor in node-positive breast cancer
    Voordeckers, M
    Vinh-Hung, V
    Van de Steene, J
    Lamote, J
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2004, 70 (03) : 225 - 230
12345